483 Abraxis Bioscience Aug 2018

483 Abraxis Bioscience Aug 2018

Jamie Dion FDA, Zachary Stamm FDA$119.00 - Available Now

FDA investigators audited the Abraxis Bioscience - Phoenix, AZ, United States facility and issued inspectional observations (via FDA 483) on 17 Aug 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 17 Aug 2018
  • Location: Phoenix, United States
  • FEI: 3006441852
Add To Cart